PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Scientific and Medical Equipment House Company

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Scientific and Medical Equipment House Company's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.

What stands out

  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.7 times. Higher than 96% of Healthcare companies in Saudi Arabia.
  • Debt Due Cover Ratio: Debt due within a year is covered 0.1 times by its yearly operating cash. Lower than 96% of Healthcare companies in Saudi Arabia.
  • Tangible Net Worth Ratio: Of every SAR 100 of net worth, SAR 100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 95% of Healthcare companies in Saudi Arabia.

Where SAR 100 of sales goes

SAR 95Operating costsSAR 2.1InterestSAR 3.2Net profitSAR 3.4Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

SAR 163

Over the last 3 years, every SAR 100 of reported profit came with SAR 163 of operating cash.

Higher than 79% of Healthcare companies in Saudi Arabia.

Self-Funding Ratio

5.7×

Over the last 3 years its own operating cash covered its investment spending (capex) 5.7 times.

Higher than 96% of Healthcare companies in Saudi Arabia.

Cash Locked Ratio

SAR 60

For every SAR 100 of sales, SAR 60 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 63 tied up three years earlier.

More money tied up than 88% of Healthcare companies in Saudi Arabia.

Growth quality

Steadiness Ratio

2/3 · 2/3

Sales grew in 2 of the last 3 years; profit grew in 2 of 3.

Less steady than 92% of Healthcare companies in Saudi Arabia.

Growth Efficiency Ratio

SAR 7

Sales grew 23% in 3 years; of every extra SAR 100 of sales, SAR 7 became extra profit.

Lower than 71% of Healthcare companies in Saudi Arabia.

Asset Productivity Ratio

+23% / +0%

In 3 years sales changed by +23% while total assets changed by +0%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.1×

Debt due within a year is covered 0.1 times by its yearly operating cash.

Lower than 96% of Healthcare companies in Saudi Arabia.

Cash Cushion Ratio

−22%

Debt, after subtracting cash, equals 22% of its market value (net debt).

Lower than 62% of Healthcare companies in Saudi Arabia.

Tangible Assets Ratio

100%

Of every SAR 100 the company owns, SAR 100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 95% of Healthcare companies in Saudi Arabia.

Tangible Net Worth Ratio

100%

Of every SAR 100 of net worth, SAR 100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 95% of Healthcare companies in Saudi Arabia.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years. Dividends paid equalled 63% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Scientific and Medical Equipment House Company owes SAR 0.51 for every SAR 1 it owns. Net profit rose 9% in the year to Dec 2025, and grew 17% a year on average over 3 years.

Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.

P/E ratio

27.8

Investors pay SAR 27.8 for every SAR 1 of Scientific and Medical Equipment House Company's yearly profit, higher than 88% of Healthcare companies in Saudi Arabia.

P/B ratio

1.55

The share price is 1.55 times Scientific and Medical Equipment House Company's book value per share, lower than 88% of Healthcare companies in Saudi Arabia.

Market cap

SAR 775 M

The total market value of all of Scientific and Medical Equipment House Company's shares at today's price (share price × number of shares), smaller than 96% of Healthcare companies in Saudi Arabia. PosiCap size class: Mini Cap.

Net worth (book value)

SAR 499 M

What Scientific and Medical Equipment House Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

SAR 16.62

Net worth divided by the number of shares. The share price of SAR 25.82 is 1.6 times this, which is the P/B above.

Return on equity (ROE)

5.0%

Scientific and Medical Equipment House Company earned 5.0% on its shareholders' money over the last year, lower than 95% of Healthcare companies in Saudi Arabia.

Owes vs Owns

0.51×

Scientific and Medical Equipment House Company owes SAR 0.51 for every SAR 1 it owns (moderate), lower than 62% of Healthcare companies in Saudi Arabia.

Dividend yield

4.09%

Scientific and Medical Equipment House Company pays 4.09% of its share price as dividends a year, higher than 71% of dividend-paying Healthcare companies in Saudi Arabia.

Revenue growth

-0%

Revenue fell 0% in the year to Dec 2025, and grew 7% a year on average over 3 years.

Profit growth

+9%

Net profit rose 9% in the year to Dec 2025, and grew 17% a year on average over 3 years.

Profit margin

3.2%

Scientific and Medical Equipment House Company keeps SAR 3 of every SAR 100 of revenue as net profit.

Cash quality

0.3×

Cash from Scientific and Medical Equipment House Company's business was 0.3× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.

Interest cover

2.1×

Scientific and Medical Equipment House Company's operating profit covered its interest costs 2.1 times in the year to Dec 2025.

Cash vs debt

Net debt

Scientific and Medical Equipment House Company had SAR 171 M more debt than cash (net debt) at Dec 2025.

Questions

What is Scientific and Medical Equipment House Company's P/E ratio?

Investors pay SAR 27.8 for every SAR 1 of Scientific and Medical Equipment House Company's yearly profit, higher than 88% of Healthcare companies in Saudi Arabia.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Scientific and Medical Equipment House Company: SAR 775 M ÷ SAR 499 M (30 Jun 2026) = 1.6.

What is Scientific and Medical Equipment House Company's return on equity?

Scientific and Medical Equipment House Company earned 5.0% on its shareholders' money over the last year, lower than 95% of Healthcare companies in Saudi Arabia.

How much does Scientific and Medical Equipment House Company owe compared with what it owns?

Scientific and Medical Equipment House Company owes SAR 0.51 for every SAR 1 it owns (moderate), lower than 62% of Healthcare companies in Saudi Arabia.

Does Scientific and Medical Equipment House Company pay a dividend?

Yes. Scientific and Medical Equipment House Company pays 4.09% of its share price as dividends a year, higher than 71% of dividend-paying Healthcare companies in Saudi Arabia.

Is Scientific and Medical Equipment House Company's revenue growing?

Revenue fell 0% in the year to Dec 2025, and grew 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.